Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Viraday-V


Contraindicated
Risk of foetal abnormalities

Contraindicated
Viraday-V :
Type Medicine Non Marketed
Originator G
Agent Droguerie de l'Union
Distributor Droguerie de l'Union
Laboratory Cipla
Responsible Party Cipla Ltd
Origin India
Manufacturer Cipla Ltd
Manufacturing Type G
Origin India
ATC J05AR06

Your comment will appear shortly after approval

Viraday-V :

Revision Date : 09/06/2015


Effect Frequency
Abdominal distension Common
Abdominal pain Common
Abnormal dreams Common
Acute kidney injury Rare
Affect lability Uncommon
Aggression Uncommon
Agitation Uncommon
ALT increased Common
Amnesia Uncommon
Amylase increased Common
Anaemia Uncommon
Angioedema (Angioneurotic oedema) (Quincke oedema) Uncommon
Anxiety Common
AST increased Common
Asthenia Very Common
Ataxia Uncommon
Autoimmune disorder Not known
Balance disorder Common
Basedow's disease Not known
Blood creatine phosphokinase increased Very Common
Blood creatinine increased Uncommon
Body fat disorder Not known
Bone disorder Rare
Bone pain Rare
Breast enlargement Not known
Chronic renal insufficiency (Renal failure chronic) Rare
Completed suicide Rare
Confusional state Uncommon
Coordination abnormal Uncommon
Decreased appetite Common
Delusion Rare
Depression Common
Dermatitis bullous Common
Diarrhoea (Diarrhea) Very Common
Disturbance in attention Common
Dizziness Common
Drug interaction Not known
Dry mouth (Xerostomia) Uncommon
Dyspepsia Common
Erythema multiforme Uncommon
Euphoric mood Uncommon
Facial wasting Not known
Fanconi syndrome Rare
Fat redistribution Not known
Fatigue Common
Flatulence Common
Flushing Uncommon
Fracture Rare
Gamma-GT increased Common
Gynecomastia (Gynaecomastia) Uncommon
Hallucination Uncommon
Headache Common
Hepatic failure (Hepatic insufficiency) (Liver failure) Rare
Hepatic steatosis Rare
Hepatitis Rare
Hepatitis acute Uncommon
Hepatomegaly Not known
Hyperbilirubinaemia Common
Hypercholesterolaemia Uncommon
Hyperglycaemia Common
Hyperlactacidaemia Not known
Hypersensitivity Common
Hypertriglyceridaemia Common
Hypokalaemia Uncommon
Hypophosphataemia Very Common
Immune reconstitution inflammatory syndrome Not known
Incoherent Uncommon
Increased appetite Uncommon
Insomnia Common
Insulin resistance Not known
Lactic acidosis Rare
Libido decreased Uncommon
Lipase increased Common
Lipodystrophy acquired Not known
Lipohypertrophy Not known
Liver disorder Not known
Maculopapular rash Common
Mania Uncommon
Muscle weakness Uncommon
Myalgia Uncommon
Myopathy Rare
Nausea Very Common
Nephritis Rare
Nephrogenic diabetes insipidus Rare
Neurosis Rare
Neutropenia Uncommon
Osteomalacia Rare
Osteonecrosis Not known
Pain Common
Pancreatitis Uncommon
Paranoia Uncommon
Photosensitivity reaction Rare
Proteinuria Uncommon
Pruritus Common
Psychotic disorders Uncommon
Rash pustular Common
Renal impairment Not known
Renal tubular disorder Rare
Renal tubular necrosis Rare
Rhabdomyolysis Uncommon
Seizures Uncommon
Skin discolouration (Dyschromia) Common
Skin hyperpigmentation Common
Skin rash Very Common
Somnolence Common
Stevens-Johnson syndrome Uncommon
Suicidal ideation Uncommon
Suicide attempt Uncommon
Thinking abnormal (Thinking disturbances) Uncommon
Tinnitus Uncommon
Transaminases increased Common
Tremor Uncommon
Tubulointerstitial nephritis Rare
Urticaria Common
Vertigo Uncommon
Vision blurred Uncommon
Vomiting Very Common

Different Units By MoH Code

Revision Date : 01/10/2013

Viraday-V Viraday-V Viraday-V Viraday-V Viraday-V Viraday-V Viraday-V

Viraday-V  MoH 6446 :
Form Tablet, Film-Coated
Package Size Box of 30
Strength 600mg/200mg/300mg
NSSF ✔
Quarantine ✔
Reg. Number 218121/09
Submission date 01/01/2009
Registration Year 2011
Archived Date 12/12/2024


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info